Guggenheim Energy & Income Fund Announces Quarterly Distribution

Written by Customer Service on September 1, 2020. Posted in Dividend Reports And Estimates.

NEW YORK, Sept. 01, 2020 (GLOBE NEWSWIRE) — Guggenheim Investments today announced that Guggenheim Energy & Income Fund (the “Fund”) (XGEIX) declared its quarterly distribution. The table below summarizes the distribution schedule for the Fund. The Fund’s CUSIP is 40169Q105.The following dates apply to the distribution:The Fund’s primary investment objective is to provide high income. As a secondary investment objective, the Fund will seek capital appreciation. There can be no assurance the Fund will achieve its investment objectives.Under normal market conditions, the Fund will invest at least 80% of its Managed Assets in (i) securities of energy companies and (ii) income producing securities of other issuers. Under normal market conditions, the Fund will invest at least 70% of its Managed Assets in securities of energy companies....

Fairfax Announces Reset Dividend Rate on its Series G Preferred Shares and Quarterly Dividend on Series C, D, E, F, G, H, I, J, K and M Preferred Shares and Quarterly Dividend Rate for Series D, F, H and J Preferred Shares

Written by Customer Service on September 1, 2020. Posted in Public Companies.

TORONTO, Sept. 01, 2020 (GLOBE NEWSWIRE) — Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) announces that it has determined the fixed dividend rate on its Cumulative 5-Year Rate Reset Preferred Shares, Series G (the “Series G Shares”) (TSX: FFH.PR.G) for the five years commencing October 1, 2020 and ending September 30, 2025. The fixed quarterly dividends on the Series G Shares during that period, if and when declared, will be paid at an annual rate of 2.962% (C$0.185125 per share per quarter).Holders of Series G Shares have the right, at their option, exercisable not later than 5:00 p.m. (Toronto time) on September 15, 2020, to convert all or part of their Series G Shares, on a one-for-one basis, into Cumulative Floating Rate Preferred Shares, Series H (the “Series H Shares”) (TSX: FFH.PR.H), effective September...

Trigon Announces Marketed Private Placement for C$5.0 Million

Written by Customer Service on September 1, 2020. Posted in Public Companies.

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES(In Canadian Dollars unless otherwise stated)TORONTO, Sept. 01, 2020 (GLOBE NEWSWIRE) — Trigon Metals Inc. (TSX-V: TM) (“Trigon” or the “Company”) announces that it has entered into an agreement with Cormark Securities Inc. (“Cormark”) as lead agent and including M Partners Inc. (collectively with Cormark the “Agents”), pursuant to which they have agreed to act as agents in connection with a fully marketed private placement offering of units of the Company (the “Units”) at a price of $0.35 per Unit for aggregate gross proceeds to the Company of a minimum of $5.0 million (the “Offering”).Each Unit will consist of one common share of the Company (a “Common Share”) and one-half of one Common Share purchase warrant (each full...

Genetic Technologies Regains Compliance with Nasdaq Stockholders Equity Requirement

Written by Customer Service on September 1, 2020. Posted in Public Companies.

MELBOURNE, Australia, Sept. 01, 2020 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, is pleased to announce that it received notification from the Listing Qualifications Department of the Nasdaq Stock Market indicating that the Company has met the minimum stockholders equity requirement set forth in Listing Rule 5550(b)(1).Nasdaq has determined that the Company complies with Listing Rule 5550(b)(1), which requires a stockholders’ equity of $2.5 million. Since April 2020, Genetic Technologies has raised an aggregate of $16.37 million through offerings of its American Depositary Shares, and as a result, as of August 28, 2020, it has US GAAP stockholders’ equity in excess of $2.5 million.Accordingly, the Company’s American...

H&R Block Announces Fiscal 2021 First Quarter Results

Written by Customer Service on September 1, 2020. Posted in Earnings Releases And Operating Results.

KANSAS CITY, Mo., Sept. 01, 2020 (GLOBE NEWSWIRE) — H&R Block, Inc. (NYSE: HRB) today released its financial results1 for the fiscal 2021 first quarter ended July 31, 2020.Strong finish to the tax season resulted in total U.S. tax filing growth of 3.3%2.Fiscal first quarter financial results improved significantly compared to the prior year due to the extension of the most recent tax season to July 15; revenues increased 300% to $601 million.Pretax earnings of $124 million compared to a pretax loss of $207 million in the prior year. GAAP earnings per share from continuing operations3 (EPS) improved to $0.48 compared to a loss of $(0.72), while non-GAAP adjusted EPS4 improved to $0.55 compared to a loss of $(0.66).Following the fiscal first quarter, the company completed the issuance of $650 million aggregate principal amount...

Berkeley Lights to Participate in the Morgan Stanley 2020 Healthcare Conference

Written by Customer Service on September 1, 2020. Posted in Public Companies.

EMERYVILLE, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) — Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be participating in the upcoming Morgan Stanley Virtual Healthcare Conference.Berkeley Lights’ management is scheduled for a fireside chat on Tuesday, September 15 at 8:00 a.m. Pacific Time / 11:00 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.berkeleylights.com.About Berkeley LightsBerkeley Lights is a leading Digital Cell Biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products for our customers. The Berkeley Lights Platform captures deep phenotypic, functional, and genotypic information...

Sun BioPharma, Inc. Closes $10.5 Million Public Offering of Common Stock and Warrants

Written by Customer Service on September 1, 2020. Posted in Public Companies.

MINNEAPOLIS, Sept. 01, 2020 (GLOBE NEWSWIRE) — Sun BioPharma, Inc. (Nasdaq:SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with pancreatic cancer, today announced the closing of its previously announced underwritten public offering of 2,545,454 shares of common stock and the same number of warrants to purchase shares of common stock for a price to the public of $4.125 per share and warrant. Gross proceeds to the company were approximately $10.5 million. Each warrant entitles the holder to purchase one share of common stock at an exercise price of $4.54 per share.Craig-Hallum Capital Group acted as sole book-running manager for the offering.A registration statement relating to the securities being sold in this offering was filed with the Securities and Exchange Commission...

Jamf Announces Second Quarter 2020 Financial Results

Written by Customer Service on September 1, 2020. Posted in Earnings Releases And Operating Results.

Q2 total revenue grew 29% year-over-year to $62.2 millionRecurring revenue grew 42% year-over-year to $58.7 millionARR grew 36% year-over-year to $241 millionMINNEAPOLIS, Sept. 01, 2020 (GLOBE NEWSWIRE) — Jamf (NASDAQ: JAMF), the standard in Apple Enterprise Management, today announced financial results for its second quarter ended June 30, 2020.Financial Highlights for the Second Quarter 2020:ARR: ARR increased 36% year-over-year to $241 million as of June 30, 2020.Revenue: Total revenue was $62.2 million, an increase of 29% year-over-year. Recurring revenue was $58.7 million, an increase of 42% year-over-year.Gross Profit: GAAP gross profit was $48.6 million, or 78% of total revenue, compared to $34.8 million, or 72% of total revenue, in the second quarter of 2019. Non-GAAP gross profit was $51.3 million, or 82% of total revenue,...

Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2020 and Recent Developments

Written by Customer Service on September 1, 2020. Posted in Earnings Releases And Operating Results.

— Recorded First Quarter Revenue of $25.4 Million —— Signed Three New Customers and Project Expansion Orders with Current Customers for $20 Million —— Backlog of $60 Million at Quarter-End —TUSTIN, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced financial results for the first quarter of fiscal 2021, ended July 31, 2020.Highlights Since April 30, 2020“Fiscal 2021 is off to a strong start as a result of the accomplishments of the first quarter,” stated Nicholas Green, president and chief executive officer of Avid...

Roche to launch SARS-CoV-2 Rapid Antigen Test in countries accepting CE mark, allowing fast triage decisions at point of care

Written by Customer Service on September 1, 2020. Posted in Public Companies.

Antigen test reliably and quickly triages people suspected of SARS-CoV-2, with results ready in 15 minutes, allowing informed treatment decisionsAntigen test accurately screens individuals with known exposure to infected SARS-CoV-2 patients, providing fast answers regarding their infection statusAffordable and small, instrument-free testing kit enables convenient use for healthcare professionals at different point of care locations, or in resource-limited settingsPoint of care testing increases access to high quality diagnostics solutions for the detection of a current SARS-CoV-2 infection, regardless of laboratory testing infrastructure or patient mobilityBasel, 1 September 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it will launch a SARS-CoV-2 Rapid Antigen Test, in late September, for markets accepting the...

Day: September 1, 2020

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice